title: [Comments of the DGP on the press release dated 21.10. 2011 of the National Heart, Lung and Blood Institute about the PANTHER Study on IPF patients].
authors.affiliation: Abteilung für Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Bochum. Juergen.behr@bergmannsheil.de
authors.forename: J
authors.initials: J
authors.lastname: Behr
authors.forename: U
authors.initials: U
authors.lastname: Costabel
authors.forename: H
authors.initials: H
authors.lastname: Worth
mesh_terms: D000111:Acetylcysteine / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine / Q000379:methods; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010919:Placebos; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D019141:Respiratory System Agents / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D010919:Placebos; D019141:Respiratory System Agents; D011239:Prednisolone; D001379:Azathioprine; D000111:Acetylcysteine